Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study

1. Mitsunaga, K.
2. Bagot, M.
3. Ram-Wolff, C.
4. Guenova, E.
5. Von Gugelberg, C.
6. Hodak, E.
7. Amitay-Laish, I.
8. Papadavid, E.
9. Jonak, C.
10. Porkert, S.
11. Scarisbrick, J.
12. Applewaite, R.
13. Beylot-Barry, M.
14. Nicolay, J.
15. Quaglino, P.
16. Sanches, J.A.
17. Cury-Martins, J.
18. Lora-Pablos, D.
19. Ortiz, P.